Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-10-7
pubmed:abstractText
p63, a member of the p53 gene family, encodes multiple proteins that may either transactivate p53 responsive genes (TAp63) or act as a dominant-negative factor toward p53 and p73 (Delta Np63). p63 is expressed in many epithelial compartments and p63(-/-) mice fail to develop skin, prostate, and mammary glands among other defects. It has been previously shown that p63 is expressed in normal urothelium. This study reports that p63 is regulated in bladder carcinogenesis and that p63 expression is lost in most invasive cancers whereas papillary superficial tumors maintain p63 expression. Examination of bladder carcinoma cell lines reveals that certain lines derived from invasive carcinomas maintain expression of Delta Np63, as demonstrated by both immunoblotting and confirmed by isoform-specific quantitative reverse transcriptase-polymerase chain reaction. Another novel finding reported in this study is the fact that p63(-/-) mice develop a bladder mucosa epithelial layer yet fail to complete uroepithelial differentiation, producing a nontransitional default cuboidal epithelium. These data indicate that in contrast to the skin and prostate, p63 is not required for formation of a bladder epithelium but is indispensable for the specific differentiation of a transitional urothelium.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10029066, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10214355, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10227293, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10227294, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10594758, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10657951, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10797291, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10805802, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10873608, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10897041, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10910040, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10918601, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-10945600, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-11023104, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-11106548, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-11252895, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-11290542, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-11457731, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-11790555, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-11839669, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-7778674, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-9662379, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-9774969, http://linkedlifedata.com/resource/pubmed/commentcorrection/12368193-9891077
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0002-9440
pubmed:author
pubmed:issnType
Print
pubmed:volume
161
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1199-206
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:12368193-Animals, pubmed-meshheading:12368193-Base Sequence, pubmed-meshheading:12368193-Carcinoma, Transitional Cell, pubmed-meshheading:12368193-Cell Differentiation, pubmed-meshheading:12368193-DNA Primers, pubmed-meshheading:12368193-DNA-Binding Proteins, pubmed-meshheading:12368193-Disease Progression, pubmed-meshheading:12368193-Gene Expression Regulation, Neoplastic, pubmed-meshheading:12368193-Genes, Tumor Suppressor, pubmed-meshheading:12368193-Humans, pubmed-meshheading:12368193-Membrane Proteins, pubmed-meshheading:12368193-Mice, pubmed-meshheading:12368193-Mice, Knockout, pubmed-meshheading:12368193-Neoplasm Invasiveness, pubmed-meshheading:12368193-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:12368193-Phosphoproteins, pubmed-meshheading:12368193-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:12368193-Trans-Activators, pubmed-meshheading:12368193-Transcription Factors, pubmed-meshheading:12368193-Tumor Cells, Cultured, pubmed-meshheading:12368193-Tumor Suppressor Proteins, pubmed-meshheading:12368193-Urinary Bladder, pubmed-meshheading:12368193-Urinary Bladder Neoplasms, pubmed-meshheading:12368193-Urinary Tract, pubmed-meshheading:12368193-Urothelium
pubmed:year
2002
pubmed:articleTitle
Loss of p63 expression is associated with tumor progression in bladder cancer.
pubmed:affiliation
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.
More...